Skip to content

NAD+

Direct mitochondrial fuel molecule essential for energy production

Intelligence Profile

Clinical Applications

NAD+ (nicotinamide adenine dinucleotide) and its precursors are being investigated for several clinical conditions, though the evidence remains limited and early-stage.

Cardiovascular Disease

One completed Phase 1/2 trial (NCT03423342) examined nicotinamide riboside, an NAD+ precursor, in patients with systolic heart failure. However, detailed results from this study are not available in the provided evidence, limiting conclusions about efficacy in heart conditions.

Neurodegenerative Diseases

Current research suggests potential applications in Alzheimer's disease and related conditions. The available literature indicates NAD+ metabolism may play roles in:

  • Metabolic reprogramming associated with Alzheimer's disease pathology
  • Tau protein acetylation processes that occur with bioenergetic impairment
  • Mitochondrial function and metabolic homeostasis through sirtuin networks

A Phase 2 trial (NCT06162013) is currently recruiting patients to study NAD replenishment therapy for atypical Parkinsonism, though results are not yet available.

Aging and Metabolic Health

Research suggests NAD+ may influence age-related processes, including circadian rhythm regulation. One study mentioned ergothioneine's effects on age-related circadian declines, though this represents indirect evidence for NAD+ pathways.

The connection between NAD+ metabolism, sirtuins, and metabolic homeostasis is an active area of investigation, with implications for diabetes and metabolic disorders.

Exercise and Performance

One completed trial (NCT04907110) examined NAD+ precursor supplementation in the context of exercise, though specific outcomes are not detailed in the available evidence.

Current Limitations

The clinical evidence for NAD+ supplementation remains preliminary. Most available data comes from mechanistic studies rather than robust clinical trials demonstrating clear therapeutic benefits. Larger, longer-term studies are needed to establish safety and efficacy profiles for specific conditions.

This information is for educational purposes only and should not replace professional medical advice. Consult healthcare providers before considering NAD+ supplementation for any medical condition.

Free account required

Clinical data requires a free AXIFI account to access clinical data, safety profiles, and research papers.